Envoy Medical (NASDAQ:COCH) & Ambu A/S (OTCMKTS:AMBBY) Head to Head Contrast

Ambu A/S (OTCMKTS:AMBBY) and Envoy Medical (NASDAQ:COCH) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.

Risk and Volatility

Ambu A/S has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.

Insider & Institutional Ownership

8.6% of Envoy Medical shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Ambu A/S and Envoy Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ambu A/S	$894.37 million	3.06	$90.19 million	$0.30	38.80
Envoy Medical	$240,000.00	191.53	-$23.76 million	($0.76)	-0.78

Ambu A/S has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Ambu A/S and Envoy Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	1	0	0	2.00
Envoy Medical	1	1	2	0	2.25

Envoy Medical has a consensus target price of $2.17, indicating a potential upside of 263.84%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than Ambu A/S.

Profitability

This table compares Ambu A/S and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	8.18%	8.49%	6.75%
Envoy Medical	-11,304.83%	N/A	-144.13%

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.